stock

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: SAB Biotherapeutics, Inc. MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc.…

1 week ago

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: CytomX Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) --…

1 week ago

KuCoin Launches Stock Index Perpetual Contracts, Expanding 24/7 Cross-Asset Access

PROVIDENCIALES, Turks and Caicos Islands, March 13, 2026 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today…

2 weeks ago

MEXC and Ondo Finance Expand Tokenized Stock Partnership with 17 New Spot Pairs and Zero-Fee Trading

VICTORIA, Seychelles, March 3, 2026 /PRNewswire/ -- MEXC, the fastest-growing global cryptocurrency exchange redefining a user-first approach to digital assets…

3 weeks ago

Elliott Management Statement on London Stock Exchange Group plc

LONDON, Feb. 27, 2026 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together…

4 weeks ago

Trading Technologies to Provide Direct Connectivity to the National Stock Exchange of India

MUMBAI, India, Feb. 25, 2026 /PRNewswire/ -- Trading Technologies International, Inc. (TT), a global capital markets technology platform services provider,…

4 weeks ago

NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 23, 2026 /PRNewswire/ -- The New York…

1 month ago

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

February 12, 2026 21:18 ET  | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus…

1 month ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

January 30, 2026 17:15 ET  | Source: Enzon Pharmaceuticals, Inc CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals,…

2 months ago

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

January 23, 2026 17:00 ET  | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) --…

2 months ago